Urinary Bladder, Overactive
Conditions
Interventions
The proposed intervention will involve bladder training and pelvic floor muscle training. The 64 women will be randomly assigned to 2 groups, one control group and the intervention group.
Control gro
Other
E02.760.169.063.500.387
Sponsors
UNICAMP- Universidade Estadual de Campinas
Pontificia Universidade Católica de Minas Gerais
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Female gender; age between 18 and 80 years; presenting an urgency symptom assessed through the questionnaire ICIQ OAB; have had the urgency symptom for more than 3 months; ave voluntary contraction of the pelvic floor muscles during inspection; sufficient literacy to fill out the necessary forms and volunteer to sign the consent form.
Exclusion criteria
Exclusion criteria: Pregnancy or intent to become pregnant during the study period; postpartum period (up to 3 months postpartum); women who have never had sexual intercourse with vaginal penetration; women who have had physiotherapy in the last year to treat the symptoms of overactive bladder; women with neurological, metabolic disorders (diabetes associated with neuropathy), or other pathology affecting the functioning of the lower urinary tract; women with suspected other bladder dysfunctions (symptoms of dysuria, suprapubic pain and / or fever, hematuria, vulvar vaginal pain); women with recurrent urinary tract infection; prolapse beyond the hymen; use of medications to control symptoms related to bladder dysfunction within 4 weeks prior to initiation of treatment; previous surgeries involving pelvic floor structures or for the intervention of symptoms of urinary incontinence in the last 6 months; cognitive disorder that compromises the individual's participation at any stage of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of episodes of urinary urgency, nocturia and urinary frequency in 24 hours, measured by the voiding diary (average of 3 days). The reduction will be observed by comparing the data collected pre-intervention, after 12 weeks of treatment and 6 months after the initial evaluation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in the volume of urinary loss measured by the 24-hour Pad Test. The reduction will be observed by comparing the data collected pre-intervention and after 12 weeks of treatment.;Improvement of the function of the pelvic floor muscles (strength, resistance, tone, pain and coordination), measured by vaginal palpation. The improvement will be seen by comparing the data collected pre-intervention and after 12 weeks of treatment.;Increased pressure of the pelvic floor muscles (resting pressure, maximum voluntary contraction and resistance), measured using pressure biofeedback (PeritronTM). The increase will be observed by comparing the data collected pre-intervention and after 12 weeks of treatment.;Impact on patients' quality of life measured using the International Consultation on Incontinence Questionnaire Overactive Bladder Quality of Life Module. The improvement will be observed by comparing the data collected pre-intervention, after 12 weeks of treatment and 6 months after the initial evaluation.;Individual satisfaction measured by the Participant's Global Improvement Impression Scale. Satisfaction will be observed by comparing the data collected after 12 weeks of treatment and 6 months after the initial assessment. | — |
Countries
Brazil
Contacts
Public ContactSílvia;Silvia Monteiro;Monteiro
Pontificia Universidade Católica de Minas Gerais;Pontificia Universidade Católica de Minas Gerais
Outcome results
None listed